BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET
BioMarin Pharmaceutical (NASDAQ: BMRN) has scheduled its second quarter 2025 financial results conference call and webcast for Monday, August 4, 2025, at 4:30 p.m. ET. The company's President and CEO, Alexander Hardy, will lead the discussion of Q2 2025 financial performance and provide business updates.
Investors and interested parties can access the live audio webcast through BioMarin's investor relations website. A replay will be available for one week after the call. The company has provided both domestic and international dial-in numbers for telephone access to the conference call.
BioMarin Pharmaceutical (NASDAQ: BMRN) ha programmato la conferenza telefonica e la trasmissione web dei risultati finanziari del secondo trimestre 2025 per lunedì 4 agosto 2025, alle 16:30 ET. Il Presidente e CEO dell'azienda, Alexander Hardy, guiderà la discussione sulle performance finanziarie del Q2 2025 e fornirà aggiornamenti aziendali.
Investitori e interessati potranno seguire la trasmissione audio in diretta tramite il sito web delle relazioni con gli investitori di BioMarin. Una replica sarà disponibile per una settimana dopo la chiamata. L'azienda ha fornito numeri di telefono sia nazionali che internazionali per accedere alla conferenza telefonica.
BioMarin Pharmaceutical (NASDAQ: BMRN) ha programado la llamada de conferencia y la transmisión web de los resultados financieros del segundo trimestre de 2025 para el lunes 4 de agosto de 2025 a las 4:30 p.m. ET. El presidente y CEO de la compañía, Alexander Hardy, dirigirá la discusión sobre el desempeño financiero del segundo trimestre de 2025 y proporcionará actualizaciones comerciales.
Los inversores y partes interesadas pueden acceder a la transmisión de audio en vivo a través del sitio web de relaciones con inversores de BioMarin. Una repetición estará disponible durante una semana después de la llamada. La compañía ha proporcionado números telefónicos tanto nacionales como internacionales para acceder a la llamada de conferencia.
BioMarin Pharmaceutical (NASDAQ: BMRN)은 2025년 2분기 재무 결과 컨퍼런스 콜 및 웹캐스트를 2025년 8월 4일 월요일 오후 4시 30분(동부 시간)에 예정했습니다. 회사의 사장 겸 CEO인 Alexander Hardy가 2025년 2분기 재무 실적에 대해 논의하고 사업 업데이트를 제공할 예정입니다.
투자자 및 관심 있는 분들은 BioMarin 투자자 관계 웹사이트를 통해 라이브 오디오 웹캐스트에 접속할 수 있습니다. 컨퍼런스 콜 종료 후 1주일간 다시 듣기 서비스가 제공됩니다. 회사는 국내외 전화 접속 번호도 함께 제공하고 있습니다.
BioMarin Pharmaceutical (NASDAQ: BMRN) a programmé sa conférence téléphonique et son webcast des résultats financiers du deuxième trimestre 2025 pour le lundi 4 août 2025 à 16h30 ET. Le président-directeur général de la société, Alexander Hardy, animera la discussion sur la performance financière du T2 2025 et fournira des mises à jour commerciales.
Les investisseurs et parties intéressées peuvent accéder au webcast audio en direct via le site des relations investisseurs de BioMarin. Un replay sera disponible pendant une semaine après l’appel. La société a fourni des numéros d’appel nationaux et internationaux pour accéder à la conférence téléphonique.
BioMarin Pharmaceutical (NASDAQ: BMRN) hat seine Telefonkonferenz und Webcast zu den Finanzergebnissen des zweiten Quartals 2025 für Montag, den 4. August 2025, um 16:30 Uhr ET angesetzt. Der Präsident und CEO des Unternehmens, Alexander Hardy, wird die Diskussion über die finanzielle Leistung des zweiten Quartals 2025 leiten und geschäftliche Updates geben.
Investoren und Interessierte können den Live-Audio-Webcast über die Investor-Relations-Website von BioMarin verfolgen. Eine Aufzeichnung wird eine Woche nach dem Anruf verfügbar sein. Das Unternehmen hat sowohl nationale als auch internationale Einwahlnummern für den Telefonzugang zur Konferenz bereitgestellt.
- None.
- None.
Dial-in Number
International Dial-in Number: 646-307-1963
Conference Call ID: 6336054
International Replay Dial-in Number: 609-800-9909
Playback ID: 6336054
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2025-financial-results-conference-call-and-webcast-on-monday-august-4-2025-at-430pm-et-302510004.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When is BioMarin (BMRN) reporting Q2 2025 earnings?
How can I listen to BioMarin's Q2 2025 earnings call?
Who will host BioMarin's Q2 2025 earnings call?
How long will BioMarin's Q2 2025 earnings call replay be available?
